Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
Guro F. Giskeødegård(Norwegian University of Science and Technology), May‐Britt Tessem(University of California, San Francisco)
Cited by 109
Related Papers
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using <sup>1</sup>H HR‐MAS spectroscopy of biopsy tissues
|Magnetic Resonance in Medicine|2008|204